Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cox regression models for quality adjusted survival analysis

B F Cole1, R D Gelber, A Goldhirsch

  • 1Department of Biostatistics, Harvard School of Public Health and Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.

Statistics in Medicine
|May 30, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.

Breast (Edinburgh, Scotland)·2022
Same author

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Reply to Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

International consensus on treatment of early breast cancer: radiotherapy issues A response to 'International expert consensus on radiotherapy of early breast cancer'.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

This study introduces a new method to incorporate patient characteristics into quality-adjusted survival analysis (Q-TWiST). This allows for a better understanding of how prognostic factors influence treatment benefits and quality of life.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Health Economics

Background:

  • Quality-adjusted survival analysis (Q-TWiST) is crucial for evaluating treatments considering both survival time and quality of life.
  • Standard Q-TWiST models patient health state transitions but doesn't easily incorporate patient-specific covariates.
  • Prognostic factors can significantly impact treatment effectiveness and patient-reported outcomes.

Purpose of the Study:

  • To develop and present an extended Q-TWiST methodology that integrates covariates using Cox's proportional hazards model.
  • To enable the profiling of patients based on their characteristics within a quality-adjusted survival framework.
  • To investigate the influence of prognostic factors on treatment benefits, specifically in terms of quality of life.

Main Methods:

Related Experiment Videos

  • The Kaplan-Meier product limit method is used to estimate state durations and transition times.
  • Survival curves for health state transitions are modeled using Cox's proportional hazards regression.
  • Quality-adjusted survival is estimated for specific sets of covariate values.

Main Results:

  • The extended Q-TWiST method successfully incorporates covariates into the survival analysis.
  • Patient profiling based on covariates is feasible, allowing for personalized outcome estimation.
  • The methodology provides insights into how prognostic factors modify treatment benefits concerning quality of life.

Conclusions:

  • The developed method enhances Q-TWiST by allowing covariate incorporation via Cox regression.
  • This approach facilitates a deeper understanding of prognostic factor impact on quality-adjusted treatment outcomes.
  • The findings are applicable to clinical trial analysis, exemplified by breast cancer treatment comparisons.